(MedPage Today) — After more than 10 years leading the Journal of the American Medical Association, editor-in-chief Catherine D. DeAngelis, MD, MPH, has announced plans to leave the post next June.
No Comments »
Filed under: General Health News
(MedPage Today) — Botox manufacturer Allergan will pay $375 million after pleading guilty to a misdemeanor misbranding charge related to off-label use of the cosmetic drug, a statement on the company’s website said.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The federal government will begin paying nearly 2,000 employers from a $5 billion fund to provide health insurance for employees who have retired early, Health and Human Services Secretary Kathleen Sebelius announced Tuesday.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA has approved a new sublingual film formulation of the opioid dependence treatment combination buprenorphrine/naloxone (Suboxone).
No Comments »
Filed under: General Health News
(MedPage Today) — Although healthcare-associated infections (HAIs) remain a large and at least partly avoidable problem in hospitals, it appears to be less of one than it was a few years ago, according to the Agency for Healthcare Research and Quality.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The Department of Health and Human Services (HHS) has named two groups that will be in charge of certifying which electronic health record systems meet the federal government’s standards for “meaningful use.”
No Comments »
Filed under: General Health News
(MedPage Today) — Botox manufacturer Allergan will pay $375 million after pleading guilty to a misdemeanor misbranding charge related to off-label use of the cosmetic drug, a statement on the company’s website said.
No Comments »
Filed under: Pharmacy News
WASHINGTON (MedPage Today) — The FDA has approved a new sublingual film formulation of the opioid dependence treatment combination buprenorphrine/naloxone (Suboxone).
No Comments »
Filed under: Pharmacy News
A substantial proportion (up to 86%) of the population living in low and middle income countries would be pushed into poverty as a result of purchasing common life-saving medicines. These are the findings of a study by Laurens Niens from Erasmus University Rotterdam and colleagues and published in this week’s PLoS Medicine…
No Comments »
Filed under: Pharmacy News
Glenmark Pharmaceuticals announced the discovery of a Novel Chemical Entity(NCE) ‘GRC 17536′. The new NCE program is targeting TRPA1 receptor antagonists for pain and respiratory disorders…
No Comments »
Filed under: Pharmacy News
